EBV-miRNA-BART22 promotes NPC cell migration and invasion and inhibits cell apoptosis by targeting ASK1 (MAP3K5), a downstream component of the p38-MAPK signaling pathway [50]. This evidence concerns the gene MAPK1 and nasopharyngeal carcinoma.